Time trends in intracranial bleeding associated with direct oral anticoagulants: a 5-year cohort study
…, SS Argentina, J Thompson, AA Chatha… - … Open Access Journal, 2015 - cmajopen.ca
Background: Over the past 5 years, dabigatran, rivaroxaban and apixaban were approved
for stroke prevention. Phase III studies have shown a lower risk of intracranial bleeding with …
for stroke prevention. Phase III studies have shown a lower risk of intracranial bleeding with …
[HTML][HTML] Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group - Lancet (London, England), 2022 - ncbi.nlm.nih.gov
Background Aspirin has been proposed as a treatment for COVID-19 on the basis of its anti-thrombotic
properties. We aimed to evaluate the efficacy and safety of aspirin in patients …
properties. We aimed to evaluate the efficacy and safety of aspirin in patients …
[HTML][HTML] Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group - Lancet (London, England), 2021 - ncbi.nlm.nih.gov
Background In this study, we aimed to evaluate the effects of tocilizumab in adult patients
admitted to hospital with COVID-19 with both hypoxia and systemic inflammation. Methods This …
admitted to hospital with COVID-19 with both hypoxia and systemic inflammation. Methods This …
[HTML][HTML] Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group - Lancet (London, England), 2021 - ncbi.nlm.nih.gov
Background Azithromycin has been proposed as a treatment for COVID-19 on the basis of its
immunomodulatory actions. We aimed to evaluate the safety and efficacy of azithromycin in …
immunomodulatory actions. We aimed to evaluate the safety and efficacy of azithromycin in …
[HTML][HTML] Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised …
RECOVERY Collaborative Group - Lancet (London, England), 2023 - ncbi.nlm.nih.gov
Background Low-dose corticosteroids have been shown to reduce mortality for patients with
COVID-19 requiring oxygen or ventilatory support (non-invasive mechanical ventilation, …
COVID-19 requiring oxygen or ventilatory support (non-invasive mechanical ventilation, …
[HTML][HTML] Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
RECOVERY Collaborative Group - Lancet (London, England), 2021 - ncbi.nlm.nih.gov
Background Many patients with COVID-19 have been treated with plasma containing anti-SARS-CoV-2
antibodies. We aimed to evaluate the safety and efficacy of convalescent plasma …
antibodies. We aimed to evaluate the safety and efficacy of convalescent plasma …